MIM
GPCR icon

Monashee Investment Management’s Structure Therapeutics GPCR Stock Holding History

Monashee Investment Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$2.41M – 33
2026
Q1 		$2.41M Sell
50,000
-175,000
-78% -$12M 1.31% 26
2025
Q4 		$15.6M Buy
225,000
+25,000
+13% +$1.02M 8.82% 1
2025
Q3 		$5.6M Sell
200,000
-230,000
-53% -$4.58M 2.79% 12
2025
Q2 		$8.92M Buy
430,000
+137,138
+47% +$3.02M 3.23% 10
2025
Q1 		$5.07M Buy
292,862
+160,862
+122% +$3.94M 0.6% 25
2024
Q4 		$3.58M Sell
132,000
-27,608
-17% -$980K 0.49% 19
2024
Q3 		$7.01M Buy
159,608
+109,608
+219% +$4.24M 0.76% 17
2024
Q2 		$1.96M Sell
50,000
-44,714
-47% -$1.84M 0.25% 44
2024
Q1 		$4.06M Sell
94,714
-97,141
-51% -$4.1M 0.48% 36
2023
Q4 		$7.82M Sell
191,855
-441,911
-70% -$25.3M 1.38% 9
2023
Q3 		$32M Sell
633,766
-737,225
-54% -$23.8M 13.35% 1
2023
Q2 		$22.8M Buy
1,370,991
+1,200,991
+706% +$33.7M 5.43% 3
2023
Q1 		$4.04M Buy
+170,000
New +$3.99M 1.12% 19

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Monashee Investment Management's GPCR Position: Q2 2026 in Review

Monashee Investment Management sold out of Structure Therapeutics (GPCR) in Q2 2026, closing a stake of 50,000 shares — an estimated $2.41M sold.

Monashee Investment Management first reported a position in GPCR in Q1 2023 and held it in 13 quarters. The position peaked at $32M in Q3 2023. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Monashee Investment Management reported no remaining Structure Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Monashee Investment Management sold 50,000 Structure Therapeutics shares in Q2 2026, an estimated $2.41M.
  • Monashee Investment Management first reported a position in Structure Therapeutics in Q1 2023 and held it in 13 quarters.
  • Monashee Investment Management's Structure Therapeutics position peaked at $32M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.